Dale Chappell, Chief Scientific Officer, 10% Owner at HUMANIGEN, INC (HGEN), sold 1,545,310 shares at $18.37 ($27.8M) on 2021-06-24, disclosed to the SEC on 2021-06-25.
Open-market sale of $27.8M HGEN by Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.28 | 9,985 | $183K | 0.7% |
| 2 | $18.28 | 9,985 | $183K | 0.7% |
| 3 | $18.28 | 26,625 | $487K | 1.8% |
| 4 | $18.28 | 26,625 | $487K | 1.8% |
| 5 | $18.28 | 96,516 | $1.8M | 6.3% |
| 6 | $18.28 | 96,516 |
| $1.8M |
| 6.3% |
| 7 | $18.37 | 10,465 | $192K | 0.7% |
| 8 | $18.37 | 10,465 | $192K | 0.7% |
| 9 | $18.37 | 27,906 | $513K | 1.8% |
| 10 | $18.37 | 27,906 | $513K | 1.8% |
| 11 | $18.37 | 101,158 | $1.9M | 6.7% |
| 12 | $18.37 | 101,158 | $1.9M | 6.7% |
| 13 | $17.80 | 75,000 | $1.3M | 4.8% |
| 14 | $17.80 | 200,000 | $3.6M | 12.8% |
| 15 | $17.80 | 725,000 | $12.9M | 46.4% |
| Total | $17.99 avg | 1,545,310 | $27.8M | 100% |
| Filing → |
| HGEN | SELL | 2021-06-21 | $18.1M | — | Filing → |
| MRFD | SELL | 2011-03-21 | $12K | — | Filing → |
| MRFD | SELL | 2011-03-14 | $21K | — | Filing → |